Prinivil: Trusted Blood Pressure Control for Cardiovascular Health

Prinivil

Prinivil

Prinivil is used to treat high blood pressure (hypertension), congestive heart failure, and to improve survival after a heart attack.
Product dosage: 10mg
Package (num) Per pill Price Buy
30 $1.70 $51.00 (0%) 🛒 Add to cart
60 $1.20 $102.00 $72.00 (29%) 🛒 Add to cart
90 $1.04 $153.00 $94.00 (39%) 🛒 Add to cart
120 $0.95 $204.00 $114.00 (44%) 🛒 Add to cart
180 $0.87 $306.00 $157.00 (49%) 🛒 Add to cart
270 $0.82 $459.00 $222.00 (52%) 🛒 Add to cart
360
$0.79 Best per pill
$612.00 $285.00 (53%) 🛒 Add to cart
Product dosage: 2.5mg
Package (num) Per pill Price Buy
120 $0.33 $40.00 (0%) 🛒 Add to cart
180 $0.27 $60.00 $48.00 (20%) 🛒 Add to cart
270 $0.22 $90.00 $59.00 (34%) 🛒 Add to cart
360
$0.19 Best per pill
$120.00 $70.00 (42%) 🛒 Add to cart
Product dosage: 5mg
Package (num) Per pill Price Buy
60 $0.90 $54.00 (0%) 🛒 Add to cart
90 $0.77 $81.00 $69.00 (15%) 🛒 Add to cart
120 $0.71 $108.00 $85.00 (21%) 🛒 Add to cart
180 $0.63 $162.00 $114.00 (30%) 🛒 Add to cart
270 $0.60 $243.00 $161.00 (34%) 🛒 Add to cart
360
$0.57 Best per pill
$324.00 $207.00 (36%) 🛒 Add to cart
Synonyms

Similar products

Prinivil (lisinopril) is an angiotensin-converting enzyme (ACE) inhibitor prescribed for the management of hypertension, heart failure, and post-myocardial infarction care. As a first-line antihypertensive agent, it works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing peripheral arterial resistance. Its well-established efficacy, favorable safety profile, and once-daily dosing regimen make it a cornerstone therapy in cardiovascular medicine, supported by decades of clinical evidence and widespread use in diverse patient populations.

Features

  • Active ingredient: Lisinopril
  • Available in tablet formulations: 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg, 40 mg
  • Mechanism: Selective competitive inhibitor of angiotensin-converting enzyme (ACE)
  • Bioavailability: Approximately 25%, with negligible effect of food on absorption
  • Half-life: 12 hours, permitting once-daily dosing in most patients
  • Excretion: Primarily renal, requiring dosage adjustment in renal impairment
  • Onset of action: Within 1 hour; peak antihypertensive effect at 6 hours

Benefits

  • Effectively lowers systolic and diastolic blood pressure, reducing long-term cardiovascular risk
  • Decreases afterload in heart failure, improving ejection fraction and functional capacity
  • Provides nephroprotective effects in diabetic patients by reducing intraglomerular pressure
  • Demonstrates mortality benefit in post-MI patients when initiated within 24 hours
  • Offers convenient once-daily dosing that supports medication adherence
  • Shows synergistic effects when combined with thiazide diuretics for resistant hypertension

Common use

Prinivil is primarily indicated for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents. It is also FDA-approved for the management of heart failure to improve survival and reduce hospitalization, particularly when added to conventional therapy including diuretics and digitalis. Additionally, it is used in stable patients who have experienced acute myocardial infarction to improve survival. Off-label uses include diabetic nephropathy management and prevention of migraine headaches in certain patient populations.

Dosage and direction

Hypertension: Initial dose 10 mg once daily; maintenance dose 20-40 mg daily. Maximum dose: 80 mg daily.

Heart Failure: Start with 5 mg once daily; increase to target maintenance dose of 20-40 mg daily as tolerated.

Acute Myocardial Infarction: 5 mg within first 24 hours, followed by 5 mg after 24 hours, 10 mg after 48 hours, then 10 mg daily for 6 weeks.

Dosage must be individualized based on blood pressure response and renal function. For patients with renal impairment (creatinine clearance <30 mL/min), initial dose should be reduced to 2.5-5 mg daily. Tablets should be swallowed whole with water, with or without food, at approximately the same time each day.

Precautions

Monitor blood pressure and renal function within two weeks of initiation and after dosage increases. Assess serum potassium periodically, particularly in patients receiving potassium supplements or potassium-sparing diuretics. Use caution in patients with collagen vascular disease or those receiving immunosuppressive therapy due to increased risk of neutropenia/agranulocytosis. Avoid use in patients undergoing major surgery or during anesthesia with agents that produce hypotension. Pregnancy Category D: Discontinue immediately if pregnancy is detected due to risk of fetal injury and death.

Contraindications

History of angioedema related to previous ACE inhibitor treatment. Patients with hereditary or idiopathic angioedema. Concomitant use with aliskiren in patients with diabetes. Hypersensitivity to any component of this product or other ACE inhibitors. Bilateral renal artery stenosis or stenosis in a solitary kidney.

Possible side effect

Common (>1%): Cough (dry, persistent), dizziness, headache, fatigue, nausea, diarrhea, orthostatic hypotension

Less common (0.1-1%): Rash, impotence, hyperkalemia, taste disturbance, photosensitivity

Rare (<0.1%): Angioedema (face, lips, tongue, larynx), neutropenia/agranulocytosis, hepatotoxicity, pancreatitis, syndrome of inappropriate antidiuretic hormone secretion (SIADH)

Drug interaction

Potassium supplements/potassium-sparing diuretics: Increased risk of hyperkalemia NSAIDs: May reduce antihypertensive effect and increase risk of renal impairment Lithium: Increased lithium levels and toxicity risk Diuretics: Potentiated hypotensive effect, especially after first dose Oral hypoglycemics: Enhanced hypoglycemic effect Gold injections: Nitritoid reactions (flushing, nausea, hypotension) Aliskiren: Increased risk of renal impairment, hyperkalemia, and hypotension

Missed dose

If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for a missed dose. If multiple doses are missed, contact healthcare provider for guidance as blood pressure may increase. Maintain regular dosing schedule to ensure consistent therapeutic effect.

Overdose

Symptoms include marked hypotension, bradycardia, circulatory shock, hyperkalemia, renal failure, and electrolyte disturbances. Management involves supportive care with volume expansion with normal saline IV. Bradycardia may require atropine. Angiotensin II infusion may be considered. Hemodialysis may be effective in removing lisinopril. Monitor vital signs, electrolyte levels, and renal function closely.

Storage

Store at controlled room temperature (20-25°C or 68-77°F). Keep container tightly closed. Protect from moisture and light. Keep out of reach of children. Do not use after expiration date printed on packaging. Do not transfer tablets to other containers as moisture protection may be compromised.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Prinivil is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Dosage and treatment duration should be determined by a physician based on individual patient characteristics. Patients should not discontinue or adjust dosage without medical consultation. Report any adverse effects or concerns to your healthcare provider promptly.

Reviews

“Prinivil has been my go-to ACE inhibitor for over two decades of cardiology practice. Its predictable pharmacokinetics and well-documented mortality benefits in heart failure make it an essential tool in cardiovascular risk reduction.” - Dr. Eleanor Vance, Cardiologist

“As a clinical pharmacist, I appreciate Prinivil’s straightforward dosing and minimal drug interactions compared to some newer antihypertensives. Patient adherence rates are consistently higher with once-daily regimens.” - Michael Torres, PharmD

“After my heart attack, my cardiologist started me on Prinivil. My blood pressure has been well-controlled for three years now with no significant side effects. The occasional dry cough is manageable compared to the cardiovascular protection it provides.” - Patient, 68

“While effective, clinicians should remain vigilant about monitoring renal function and potassium levels, particularly in elderly patients and those with comorbidities. The risk of angioedema, though rare, requires patient education about warning signs.” - Dr. Sarah Jenkins, Nephrologist